You are here: All Products  > Luye Enrolls Last Patient in Phase III Trial of Eylea Biosimilar

Luye Enrolls Last Patient in Phase III Trial of Eylea Biosimilar

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products